Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FTC's Prevagen Complaint Revived: Court Says 'Deceptive' Ad Allegation Plausible

Mar 06 2019

• By Eileen Francis

Related Content

FTC Leaves Supplement Industry Still Waiting For Shift Away From RCT Standard For Claims

Jul 06 2016

New York AG And FTC Target Prevagen Memory Claims

Jan 10 2017

<em>Prevagen</em> Study Data Withstand False Ad Complaint By FTC, New York AG

Oct 05 2017

Criminal Case In PR, FTC Appeal In NY, GNC In India: Health And Wellness Industry News

Mar 08 2018

Imposing RCTs For Supplement Claims Would Cause 'Wholesale Change' In Regulation – CRN, CHPA

Jun 13 2018

Clinical Trials For Supplement Claims Not An FTC Rule, But A Standard

Aug 24 2018

Additional Topics

United States Dietary Supplements Advertising, Marketing & Sales Regulation Ad Campaigns Companies Commercial Enforcement Legal Issues Manufacturing Policy Neurology Consumer

More from Marketing & Advertising

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window